Pepeflabs的个人主页 - 老虎社区

Pepeflabs

Pepeflabs

STONKS

IP属地：未知

175关注

1387粉丝

1主题

0勋章

2022-01-27

$Uber(UBER)$all the way

2022-01-25

Noted

Netflix Slumps Another 6%, Jefferies Says Content Alone Isn't Cutting It for TV Streamer<blockquote>杰富瑞(Jefferies)表示，Netflix股价又下跌6%，仅靠内容并不能影响电视流媒体业务</blockquote>

2022-01-23

Noted

US IPO Week Ahead: Connectivity Solutions and Micro-caps in a 5 IPO week<blockquote>美国IPO周：5周IPO中的连接解决方案和微型股</blockquote>

2022-01-19

Ok

抱歉，原内容已删除

2022-01-19

Pookillao

抱歉，原内容已删除

2022-01-16

All the wayy

抱歉，原内容已删除

2022-01-16

Gope

抱歉，原内容已删除

2022-01-16

基督教大家

抱歉，原内容已删除

2022-01-15

Gogo

抱歉，原内容已删除

2022-01-12

$Apple(AAPL)$lope

2022-01-09

Kekepoe

3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>

2022-01-08

Xjdjd

抱歉，原内容已删除

2022-01-05

$Apple(AAPL)$upup

2022-01-05

$Apple(AAPL)$to the moon

2022-01-03

$Apple(AAPL)$all the wayy

2022-01-02

Gogo

抱歉，原内容已删除

2021-12-31

$Apple(AAPL)$all the wayy

2021-12-30

Very nicee

抱歉，原内容已删除

2021-12-30

Llol pee

抱歉，原内容已删除

2021-12-26

$Apple(AAPL)$gogogo

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3573162818118967","uuid":"3573162818118967","gmtCreate":1610068795040,"gmtModify":1612353260885,"name":"Pepeflabs","pinyin":"pepeflabs","introduction":"","introductionEn":null,"signature":"STONKS","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1387,"headSize":175,"tweetSize":353,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":4,"name":"文化虎","nameTw":"文化虎","represent":"学有所成","factor":"发布30条非转发主帖,其中3条优质帖","iconColor":"8867FB","bgColor":"BDC5FF"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"93.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":639658476,"gmtCreate":1643284532438,"gmtModify":1643554862691,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UBER\">$Uber(UBER)$</a>all the way","listText":"<a href=\"https://laohu8.com/S/UBER\">$Uber(UBER)$</a>all the way","text":"$Uber(UBER)$all the way","images":[{"img":"https://static.tigerbbs.com/b31d8daa5246e912cd224d6d65cd59d4","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":73,"commentSize":18,"repostSize":1,"link":"https://laohu8.com/post/639658476","isVote":1,"tweetType":1,"viewCount":4074,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630782569,"gmtCreate":1643042439462,"gmtModify":1643297712695,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/630782569","repostId":"1153487783","repostType":4,"repost":{"id":"1153487783","kind":"news","pubTimestamp":1643036174,"share":"https://www.laohu8.com/m/news/1153487783?lang=zh_CN&edition=full","pubTime":"2022-01-24 22:56","market":"us","language":"en","title":"Netflix Slumps Another 6%, Jefferies Says Content Alone Isn't Cutting It for TV Streamer<blockquote>杰富瑞(Jefferies)表示，Netflix股价又下跌6%，仅靠内容并不能影响电视流媒体业务</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1153487783","media":"Seeking Alpha","summary":"Investors sentiments about Netflix(NASDAQ:NFLX)failed to soften over the weekend as they sent the st","content":"<p><html><head></head><body><ul><li>Investors sentiments about Netflix(NASDAQ:NFLX)failed to soften over the weekend as they sent the streaming TV giant&#39;s shares down more than 6%, Monday, and Jefferies analyst Andrew Uerkiwitz cut his rating on the company&#39;s stock.</li><li>Uerkwitz took his view of Netflix (NFLX) to hold from buy, saying there is &#34;too much uncertainty in the near term&#34; surrounding the company following its disappointing quarterly report and outlook last week. On Thursday, Netflix (NFLX) said it added 8.28 million new subscribers during the fourth quarter of 2021, which fell short of its earlier forecasts of 8.5 million subscriber additions. Netflix (NFLX) also said it expects to add just 2.5 million subscribers during the first quarter of this year.</li><li>Those numbers did Netflix (NFLX) no favors on Wall Street, as investors drove the company&#39;s shares down almost 22% on Friday.</li><li>On Monday, Uerkwitz joined in what was a mostly negative chorus in response to Netflix&#39;s (NFLX) subscriber numbers, saying that after &#34;thinking through potential scenarios for what happens next&#34; for the company, it appears Netflix&#39;s (NFLX) spending on new content could be coming to a head.</li><li>&#34;Netflix subscribers are going nowhere,&#34; Uerkwitz said. &#34;However, the cost of acquiring the incremental subscriber has likely become too high.&#34;</li><li>Ueurwitz added that it seems like Netflix (NFLX) can&#39;t just rely on creating a sense of prestige, or exclusivity, around its own original content to drive multitudes of new subscribers to its service.</li><li>&#34;The best content slate we&#39;ve seen is doing little to drive [subscriber] growth,&#34; Uerkwitz said. &#34;If slower subscriber growth is the new normal, we would need to see a change in content [and] captial allocation coupled with a focus on new revenue streams to leverage the large user base [and] content library.&#34;</li><li>Over the weekend, TV ratings-measurement company Nielsen(NYSE:NLSN)released data from its &#34;Streaming Unwrapped 2021&#34; report, which showed Netflix (NFLX) claiming the top nine slots for original programming streamed online. The show<i>Lucifer</i>, topped the chart,with 18.34 billion minutes streamed last year.</li></ul></body></html></p><p><blockquote><html><head></head><body><ul><li>投资者对Netflix（纳斯达克股票代码：NFLX）的情绪在周末未能软化，导致这家流媒体电视巨头的股价周一下跌超过6%，杰富瑞(Jefferies)分析师Andrew Uerkiwitz下调了对该公司股票的评级。</li><li>Uerkwitz将Netflix(NFLX)的看法从买入调整为持有，他表示，在上周令人失望的季度报告和前景之后，该公司“短期内存在太多不确定性”。周四，Netflix(NFLX)表示，2021年第四季度新增用户828万，低于此前预测的新增用户850万。Netflix(NFLX)还表示，预计今年第一季度仅增加250万订阅用户。</li><li>这些数字在华尔街对Netflix(NFLX)没有任何好处，投资者周五导致该公司股价下跌近22%。</li><li>周一，Uerkwitz加入了对Netflix(NFLX)用户数量的负面回应，他表示，在“考虑了该公司接下来发生的潜在情况”后，Netflix(NFLX)在新内容上的支出似乎可能会达到顶峰。</li><li>Netflix, Inc.用户哪儿也去不了，”乌尔克维茨说。“然而，获取增量用户的成本可能太高了。”</li><li>Ueurwitz补充说，Netflix(NFLX)似乎不能仅仅依靠围绕其原创内容创造声望或排他性来吸引大量新订阅者使用其服务。</li><li>“我们所见过的最好的内容对推动[订户]增长几乎没有什么作用，”乌尔克维茨说。“如果订户增长放缓成为新常态，我们需要看到内容[和]资本配置的变化，同时关注新的收入来源，以利用庞大的用户群[和]内容库。”</li><li>周末，电视收视率测量公司尼尔森（纽约证券交易所股票代码：NLSN）发布了其“2021年流媒体Unwrapped”报告中的数据，该报告显示Netflix（NFLX）占据了在线流媒体原创节目的前九名。节目<i>路西法</i>，以183.4亿分钟的流媒体播放量位居榜首。</li></ul></body></html></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Slumps Another 6%, Jefferies Says Content Alone Isn't Cutting It for TV Streamer<blockquote>杰富瑞(Jefferies)表示，Netflix股价又下跌6%，仅靠内容并不能影响电视流媒体业务</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Slumps Another 6%, Jefferies Says Content Alone Isn't Cutting It for TV Streamer<blockquote>杰富瑞(Jefferies)表示，Netflix股价又下跌6%，仅靠内容并不能影响电视流媒体业务</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2022-01-24 22:56</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body><ul><li>Investors sentiments about Netflix(NASDAQ:NFLX)failed to soften over the weekend as they sent the streaming TV giant&#39;s shares down more than 6%, Monday, and Jefferies analyst Andrew Uerkiwitz cut his rating on the company&#39;s stock.</li><li>Uerkwitz took his view of Netflix (NFLX) to hold from buy, saying there is &#34;too much uncertainty in the near term&#34; surrounding the company following its disappointing quarterly report and outlook last week. On Thursday, Netflix (NFLX) said it added 8.28 million new subscribers during the fourth quarter of 2021, which fell short of its earlier forecasts of 8.5 million subscriber additions. Netflix (NFLX) also said it expects to add just 2.5 million subscribers during the first quarter of this year.</li><li>Those numbers did Netflix (NFLX) no favors on Wall Street, as investors drove the company&#39;s shares down almost 22% on Friday.</li><li>On Monday, Uerkwitz joined in what was a mostly negative chorus in response to Netflix&#39;s (NFLX) subscriber numbers, saying that after &#34;thinking through potential scenarios for what happens next&#34; for the company, it appears Netflix&#39;s (NFLX) spending on new content could be coming to a head.</li><li>&#34;Netflix subscribers are going nowhere,&#34; Uerkwitz said. &#34;However, the cost of acquiring the incremental subscriber has likely become too high.&#34;</li><li>Ueurwitz added that it seems like Netflix (NFLX) can&#39;t just rely on creating a sense of prestige, or exclusivity, around its own original content to drive multitudes of new subscribers to its service.</li><li>&#34;The best content slate we&#39;ve seen is doing little to drive [subscriber] growth,&#34; Uerkwitz said. &#34;If slower subscriber growth is the new normal, we would need to see a change in content [and] captial allocation coupled with a focus on new revenue streams to leverage the large user base [and] content library.&#34;</li><li>Over the weekend, TV ratings-measurement company Nielsen(NYSE:NLSN)released data from its &#34;Streaming Unwrapped 2021&#34; report, which showed Netflix (NFLX) claiming the top nine slots for original programming streamed online. The show<i>Lucifer</i>, topped the chart,with 18.34 billion minutes streamed last year.</li></ul></body></html></p><p><blockquote><html><head></head><body><ul><li>投资者对Netflix（纳斯达克股票代码：NFLX）的情绪在周末未能软化，导致这家流媒体电视巨头的股价周一下跌超过6%，杰富瑞(Jefferies)分析师Andrew Uerkiwitz下调了对该公司股票的评级。</li><li>Uerkwitz将Netflix(NFLX)的看法从买入调整为持有，他表示，在上周令人失望的季度报告和前景之后，该公司“短期内存在太多不确定性”。周四，Netflix(NFLX)表示，2021年第四季度新增用户828万，低于此前预测的新增用户850万。Netflix(NFLX)还表示，预计今年第一季度仅增加250万订阅用户。</li><li>这些数字在华尔街对Netflix(NFLX)没有任何好处，投资者周五导致该公司股价下跌近22%。</li><li>周一，Uerkwitz加入了对Netflix(NFLX)用户数量的负面回应，他表示，在“考虑了该公司接下来发生的潜在情况”后，Netflix(NFLX)在新内容上的支出似乎可能会达到顶峰。</li><li>Netflix, Inc.用户哪儿也去不了，”乌尔克维茨说。“然而，获取增量用户的成本可能太高了。”</li><li>Ueurwitz补充说，Netflix(NFLX)似乎不能仅仅依靠围绕其原创内容创造声望或排他性来吸引大量新订阅者使用其服务。</li><li>“我们所见过的最好的内容对推动[订户]增长几乎没有什么作用，”乌尔克维茨说。“如果订户增长放缓成为新常态，我们需要看到内容[和]资本配置的变化，同时关注新的收入来源，以利用庞大的用户群[和]内容库。”</li><li>周末，电视收视率测量公司尼尔森（纽约证券交易所股票代码：NLSN）发布了其“2021年流媒体Unwrapped”报告中的数据，该报告显示Netflix（NFLX）占据了在线流媒体原创节目的前九名。节目<i>路西法</i>，以183.4亿分钟的流媒体播放量位居榜首。</li></ul></body></html></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3790719-netflix-slumps-another-6-jefferies-says-content-alone-isnt-cutting-it-for-tv-streamer\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://seekingalpha.com/news/3790719-netflix-slumps-another-6-jefferies-says-content-alone-isnt-cutting-it-for-tv-streamer","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153487783","content_text":"Investors sentiments about Netflix(NASDAQ:NFLX)failed to soften over the weekend as they sent the streaming TV giant's shares down more than 6%, Monday, and Jefferies analyst Andrew Uerkiwitz cut his rating on the company's stock.Uerkwitz took his view of Netflix (NFLX) to hold from buy, saying there is \"too much uncertainty in the near term\" surrounding the company following its disappointing quarterly report and outlook last week. On Thursday, Netflix (NFLX) said it added 8.28 million new subscribers during the fourth quarter of 2021, which fell short of its earlier forecasts of 8.5 million subscriber additions. Netflix (NFLX) also said it expects to add just 2.5 million subscribers during the first quarter of this year.Those numbers did Netflix (NFLX) no favors on Wall Street, as investors drove the company's shares down almost 22% on Friday.On Monday, Uerkwitz joined in what was a mostly negative chorus in response to Netflix's (NFLX) subscriber numbers, saying that after \"thinking through potential scenarios for what happens next\" for the company, it appears Netflix's (NFLX) spending on new content could be coming to a head.\"Netflix subscribers are going nowhere,\" Uerkwitz said. \"However, the cost of acquiring the incremental subscriber has likely become too high.\"Ueurwitz added that it seems like Netflix (NFLX) can't just rely on creating a sense of prestige, or exclusivity, around its own original content to drive multitudes of new subscribers to its service.\"The best content slate we've seen is doing little to drive [subscriber] growth,\" Uerkwitz said. \"If slower subscriber growth is the new normal, we would need to see a change in content [and] captial allocation coupled with a focus on new revenue streams to leverage the large user base [and] content library.\"Over the weekend, TV ratings-measurement company Nielsen(NYSE:NLSN)released data from its \"Streaming Unwrapped 2021\" report, which showed Netflix (NFLX) claiming the top nine slots for original programming streamed online. The showLucifer, topped the chart,with 18.34 billion minutes streamed last year.","news_type":1,"symbols_score_info":{"NFLX":0.9}},"isVote":1,"tweetType":1,"viewCount":4059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630500567,"gmtCreate":1642949876833,"gmtModify":1642950560264,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/630500567","repostId":"1177633565","repostType":4,"repost":{"id":"1177633565","kind":"news","pubTimestamp":1642897739,"share":"https://www.laohu8.com/m/news/1177633565?lang=zh_CN&edition=full","pubTime":"2022-01-23 08:28","market":"us","language":"en","title":"US IPO Week Ahead: Connectivity Solutions and Micro-caps in a 5 IPO week<blockquote>美国IPO周：5周IPO中的连接解决方案和微型股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1177633565","media":"Renaissance Capital","summary":"Following a week of postponements and pricing delays, two tech IPOs and three holdovers are schedule","content":"<p><html><head></head><body>Following a week of postponements and pricing delays, two tech IPOs and three holdovers are scheduled to raise $412 million in the week ahead.</p><p><blockquote><html><head></head><body>经过一周的推迟和定价延迟，两起科技IPO和三起延期IPO计划在未来一周筹集4.12亿美元。</body></html></blockquote></p><p>Connectivity solutions provider Credo Technology Group (CRDO) plans to raise $275 million at a $1.8 billion market cap. Credo’s solutions are optimized for optical and electrical ethernet applications, and its product families include Integrated Circuits, Active Electrical Cables, and SerDes Chiplets. Unprofitable with accelerating growth in the 1H FY21, the company is relatively small and competes with much larger players. New investors have indicated on $120 million of the IPO (44% of the deal).</p><p><blockquote>连接解决方案提供商Credo Technology Group(CRDO)计划以18亿美元的市值筹集2.75亿美元。Credo的解决方案针对光学和电气以太网应用进行了优化，其产品系列包括集成电路、有源电缆和SerDes小芯片。随着2021财年上半年的加速增长，该公司规模相对较小，并与规模大得多的企业竞争。新投资者已表示将投资1.2亿美元（占交易的44%）。</blockquote></p><p>AdTech platform Direct Digital Holdings (DRCT) plans to raise $32 million at a $123 million market cap. Direct Digital is an end-to-end, full-service programmatic advertising platform focused on both buy- and sell-side digital advertising. The company is profitable, and while it has delivered explosive growth, it has mostly been fueled by acquisitions.</p><p><blockquote>广告技术平台Direct Digital Holdings(DRCT)计划以1.23亿美元的市值筹集3200万美元。Direct Digital是一个端到端、全方位服务的程序化广告平台，专注于买方和卖方的数字广告。该公司是盈利的，虽然它实现了爆炸性增长，但主要是由收购推动的。</blockquote></p><p>Three holdovers from the past week are scheduled to debut: Australian green energy company Verdant Earth Technologies (VDNT) plans to raise $50 million at a $201 million market cap; OTC-listed Modular Medical (MODD) plans to raise $30 million at a $130 million market cap; and medical device maker Samsara Vision (SMSA) plans to raise $25 million at a $153 million market cap.</p><p><blockquote>过去一周的三家留任公司计划首次亮相：澳大利亚绿色能源公司Verdant Earth Technologies(VDNT)计划以2.01亿美元的市值筹集5000万美元；OTC上市的Modular Medical(MODD)计划以1.3亿美元的市值筹集3000万美元；医疗设备制造商Samsara Vision(SMSA)计划以1.53亿美元的市值筹集2500万美元。</blockquote></p><p><img src=\"https://static.tigerbbs.com/86582e3564e0e81ff68668b2556d5ac9\" tg-width=\"1417\" tg-height=\"695\" width=\"100%\" height=\"auto\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Connectivity Solutions and Micro-caps in a 5 IPO week<blockquote>美国IPO周：5周IPO中的连接解决方案和微型股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Connectivity Solutions and Micro-caps in a 5 IPO week<blockquote>美国IPO周：5周IPO中的连接解决方案和微型股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Renaissance Capital</strong><span class=\"h-time small\">2022-01-23 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Following a week of postponements and pricing delays, two tech IPOs and three holdovers are scheduled to raise $412 million in the week ahead.</p><p><blockquote><html><head></head><body>经过一周的推迟和定价延迟，两起科技IPO和三起延期IPO计划在未来一周筹集4.12亿美元。</body></html></blockquote></p><p>Connectivity solutions provider Credo Technology Group (CRDO) plans to raise $275 million at a $1.8 billion market cap. Credo’s solutions are optimized for optical and electrical ethernet applications, and its product families include Integrated Circuits, Active Electrical Cables, and SerDes Chiplets. Unprofitable with accelerating growth in the 1H FY21, the company is relatively small and competes with much larger players. New investors have indicated on $120 million of the IPO (44% of the deal).</p><p><blockquote>连接解决方案提供商Credo Technology Group(CRDO)计划以18亿美元的市值筹集2.75亿美元。Credo的解决方案针对光学和电气以太网应用进行了优化，其产品系列包括集成电路、有源电缆和SerDes小芯片。随着2021财年上半年的加速增长，该公司规模相对较小，并与规模大得多的企业竞争。新投资者已表示将投资1.2亿美元（占交易的44%）。</blockquote></p><p>AdTech platform Direct Digital Holdings (DRCT) plans to raise $32 million at a $123 million market cap. Direct Digital is an end-to-end, full-service programmatic advertising platform focused on both buy- and sell-side digital advertising. The company is profitable, and while it has delivered explosive growth, it has mostly been fueled by acquisitions.</p><p><blockquote>广告技术平台Direct Digital Holdings(DRCT)计划以1.23亿美元的市值筹集3200万美元。Direct Digital是一个端到端、全方位服务的程序化广告平台，专注于买方和卖方的数字广告。该公司是盈利的，虽然它实现了爆炸性增长，但主要是由收购推动的。</blockquote></p><p>Three holdovers from the past week are scheduled to debut: Australian green energy company Verdant Earth Technologies (VDNT) plans to raise $50 million at a $201 million market cap; OTC-listed Modular Medical (MODD) plans to raise $30 million at a $130 million market cap; and medical device maker Samsara Vision (SMSA) plans to raise $25 million at a $153 million market cap.</p><p><blockquote>过去一周的三家留任公司计划首次亮相：澳大利亚绿色能源公司Verdant Earth Technologies(VDNT)计划以2.01亿美元的市值筹集5000万美元；OTC上市的Modular Medical(MODD)计划以1.3亿美元的市值筹集3000万美元；医疗设备制造商Samsara Vision(SMSA)计划以1.53亿美元的市值筹集2500万美元。</blockquote></p><p><img src=\"https://static.tigerbbs.com/86582e3564e0e81ff68668b2556d5ac9\" tg-width=\"1417\" tg-height=\"695\" width=\"100%\" height=\"auto\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/90382/US-IPO-Week-Ahead-Connectivity-solutions-and-micro-caps-in-a-5-IPO-week\">Renaissance Capital</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DRCT":"Direct Digital Holdings, Inc.","CRDO":"Credo Technology Group Holding Ltd","MODD":"Modular Medical, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/90382/US-IPO-Week-Ahead-Connectivity-solutions-and-micro-caps-in-a-5-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177633565","content_text":"Following a week of postponements and pricing delays, two tech IPOs and three holdovers are scheduled to raise $412 million in the week ahead.Connectivity solutions provider Credo Technology Group (CRDO) plans to raise $275 million at a $1.8 billion market cap. Credo’s solutions are optimized for optical and electrical ethernet applications, and its product families include Integrated Circuits, Active Electrical Cables, and SerDes Chiplets. Unprofitable with accelerating growth in the 1H FY21, the company is relatively small and competes with much larger players. New investors have indicated on $120 million of the IPO (44% of the deal).AdTech platform Direct Digital Holdings (DRCT) plans to raise $32 million at a $123 million market cap. Direct Digital is an end-to-end, full-service programmatic advertising platform focused on both buy- and sell-side digital advertising. The company is profitable, and while it has delivered explosive growth, it has mostly been fueled by acquisitions.Three holdovers from the past week are scheduled to debut: Australian green energy company Verdant Earth Technologies (VDNT) plans to raise $50 million at a $201 million market cap; OTC-listed Modular Medical (MODD) plans to raise $30 million at a $130 million market cap; and medical device maker Samsara Vision (SMSA) plans to raise $25 million at a $153 million market cap.","news_type":1,"symbols_score_info":{"CRDO":0.9,"DRCT":0.9,"MODD":0.9}},"isVote":1,"tweetType":1,"viewCount":3570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697553837,"gmtCreate":1642525818926,"gmtModify":1642525832497,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697553837","repostId":"2204470453","repostType":4,"isVote":1,"tweetType":1,"viewCount":3406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697553391,"gmtCreate":1642525813095,"gmtModify":1642526451050,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Pookillao","listText":"Pookillao","text":"Pookillao","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697553391","repostId":"2204470453","repostType":4,"isVote":1,"tweetType":1,"viewCount":2872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697136723,"gmtCreate":1642346510380,"gmtModify":1642346522635,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"All the wayy","listText":"All the wayy","text":"All the wayy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697136723","repostId":"2203742646","repostType":4,"isVote":1,"tweetType":1,"viewCount":3417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697136423,"gmtCreate":1642346503641,"gmtModify":1642383337979,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Gope","listText":"Gope","text":"Gope","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697136423","repostId":"2203742646","repostType":4,"isVote":1,"tweetType":1,"viewCount":3189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697136527,"gmtCreate":1642346494786,"gmtModify":1642383350425,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"基督教大家","listText":"基督教大家","text":"基督教大家","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697136527","repostId":"2203742646","repostType":4,"isVote":1,"tweetType":1,"viewCount":2999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697909360,"gmtCreate":1642184536287,"gmtModify":1642348758067,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Gogo","listText":"Gogo","text":"Gogo","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/697909360","repostId":"1106311032","repostType":4,"isVote":1,"tweetType":1,"viewCount":3447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694870812,"gmtCreate":1641918611783,"gmtModify":1642186654413,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>lope","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>lope","text":"$Apple(AAPL)$lope","images":[{"img":"https://static.tigerbbs.com/aa006190aa6a09c655ae0dc75fff942a","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/694870812","isVote":1,"tweetType":1,"viewCount":2733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":694094958,"gmtCreate":1641675250379,"gmtModify":1641743686225,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Kekepoe","listText":"Kekepoe","text":"Kekepoe","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/694094958","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://www.laohu8.com/m/news/1134509683?lang=zh_CN&edition=full","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2022-01-08 11:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"PFE":0.9,"NVAX":0.9,"VIR":0.9}},"isVote":1,"tweetType":1,"viewCount":1032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695710139,"gmtCreate":1641576632043,"gmtModify":1641674560869,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Xjdjd","listText":"Xjdjd","text":"Xjdjd","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/695710139","repostId":"2201216295","repostType":4,"isVote":1,"tweetType":1,"viewCount":1599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695817719,"gmtCreate":1641397164764,"gmtModify":1641397740546,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>upup","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>upup","text":"$Apple(AAPL)$upup","images":[{"img":"https://static.tigerbbs.com/106a50a9a3766eeae2938a5708231052","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/695817719","isVote":1,"tweetType":1,"viewCount":1358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":695307998,"gmtCreate":1641314925553,"gmtModify":1641314937531,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>to the moon","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>to the moon","text":"$Apple(AAPL)$to the moon","images":[{"img":"https://static.tigerbbs.com/ddd926218821667fe5c774ec89219575","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695307998","isVote":1,"tweetType":1,"viewCount":1126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":692434949,"gmtCreate":1641159024736,"gmtModify":1641159037158,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","text":"$Apple(AAPL)$all the wayy","images":[{"img":"https://static.tigerbbs.com/1826373095222ecd45cef7fb24a74076","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":86,"commentSize":36,"repostSize":0,"link":"https://laohu8.com/post/692434949","isVote":1,"tweetType":1,"viewCount":2792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":692565906,"gmtCreate":1641068217317,"gmtModify":1641158421767,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Gogo","listText":"Gogo","text":"Gogo","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/692565906","repostId":"2200448674","repostType":4,"isVote":1,"tweetType":1,"viewCount":1615,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692147701,"gmtCreate":1640888173045,"gmtModify":1640974174693,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","text":"$Apple(AAPL)$all the wayy","images":[{"img":"https://static.tigerbbs.com/9074736545fb48c9d1b023aff11eb4b9","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/692147701","isVote":1,"tweetType":1,"viewCount":1370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":692369551,"gmtCreate":1640851094630,"gmtModify":1641068126462,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Very nicee","listText":"Very nicee","text":"Very nicee","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/692369551","repostId":"2195468434","repostType":4,"isVote":1,"tweetType":1,"viewCount":1316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692369232,"gmtCreate":1640851082362,"gmtModify":1640853818630,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"Llol pee","listText":"Llol pee","text":"Llol pee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692369232","repostId":"2195468434","repostType":4,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698794374,"gmtCreate":1640529578623,"gmtModify":1640547511148,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573162818118967","authorIdStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>gogogo","text":"$Apple(AAPL)$gogogo","images":[{"img":"https://static.tigerbbs.com/f2f4f0d95f0e3e9f4ffd9b42c3b7d502","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":319,"commentSize":122,"repostSize":6,"link":"https://laohu8.com/post/698794374","isVote":1,"tweetType":1,"viewCount":8432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":698984701,"gmtCreate":1640276511234,"gmtModify":1640277099142,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all yhe wayy","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all yhe wayy","text":"$Apple(AAPL)$all yhe wayy","images":[{"img":"https://static.tigerbbs.com/f539a2d345d64aae87cd97acad04f2a0","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1824,"commentSize":870,"repostSize":13,"link":"https://laohu8.com/post/698984701","isVote":1,"tweetType":1,"viewCount":35463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842487103,"gmtCreate":1636219313219,"gmtModify":1636221574822,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Lets be goooo","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Lets be goooo","text":"$Apple(AAPL)$Lets be goooo","images":[{"img":"https://static.tigerbbs.com/ec8a857aa32b0d5d7dbae93762e1e84e","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1124,"commentSize":248,"repostSize":5,"link":"https://laohu8.com/post/842487103","isVote":1,"tweetType":1,"viewCount":16237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847986186,"gmtCreate":1636472130096,"gmtModify":1636472802533,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Konk","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Konk","text":"$Apple(AAPL)$Konk","images":[{"img":"https://static.tigerbbs.com/6f5839d3340c1bba808b27d63000ee86","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1051,"commentSize":205,"repostSize":2,"link":"https://laohu8.com/post/847986186","isVote":1,"tweetType":1,"viewCount":12403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":698794374,"gmtCreate":1640529578623,"gmtModify":1640547511148,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>gogogo","text":"$Apple(AAPL)$gogogo","images":[{"img":"https://static.tigerbbs.com/f2f4f0d95f0e3e9f4ffd9b42c3b7d502","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":319,"commentSize":122,"repostSize":6,"link":"https://laohu8.com/post/698794374","isVote":1,"tweetType":1,"viewCount":8432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":602764602,"gmtCreate":1639072257632,"gmtModify":1639149039848,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>wow","listText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>wow","text":"$Blue Sphere Corp.(BLSP)$wow","images":[{"img":"https://static.tigerbbs.com/4d1da8b9c8e4d7955d3fec38beb27c58","width":"1080","height":"3585"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":120,"commentSize":36,"repostSize":0,"link":"https://laohu8.com/post/602764602","isVote":1,"tweetType":1,"viewCount":2647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":692434949,"gmtCreate":1641159024736,"gmtModify":1641159037158,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>all the wayy","text":"$Apple(AAPL)$all the wayy","images":[{"img":"https://static.tigerbbs.com/1826373095222ecd45cef7fb24a74076","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":86,"commentSize":36,"repostSize":0,"link":"https://laohu8.com/post/692434949","isVote":1,"tweetType":1,"viewCount":2792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":639658476,"gmtCreate":1643284532438,"gmtModify":1643554862691,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UBER\">$Uber(UBER)$</a>all the way","listText":"<a href=\"https://laohu8.com/S/UBER\">$Uber(UBER)$</a>all the way","text":"$Uber(UBER)$all the way","images":[{"img":"https://static.tigerbbs.com/b31d8daa5246e912cd224d6d65cd59d4","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":73,"commentSize":18,"repostSize":1,"link":"https://laohu8.com/post/639658476","isVote":1,"tweetType":1,"viewCount":4074,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":198725655,"gmtCreate":1620993326677,"gmtModify":1634194722504,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Every single week you see articles saying how the media potrays this as one of the worst stocks to buy.But really all they are telling us is that they are the worst information outlet to trust.&nbsp;On June 2 they will find out the actual float for&nbsp;<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>which could potentially expose a ton of synthethic shares (Failure to deliver / Naked shorts).Hold on apess coz we are going to the moon!![财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Every single week you see articles saying how the media potrays this as one of the worst stocks to buy.But really all they are telling us is that they are the worst information outlet to trust.&nbsp;On June 2 they will find out the actual float for&nbsp;<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>which could potentially expose a ton of synthethic shares (Failure to deliver / Naked shorts).Hold on apess coz we are going to the moon!![财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","text":"$AMC Entertainment(AMC)$Every single week you see articles saying how the media potrays this as one of the worst stocks to buy.But really all they are telling us is that they are the worst information outlet to trust. On June 2 they will find out the actual float for $AMC Entertainment(AMC)$which could potentially expose a ton of synthethic shares (Failure to deliver / Naked shorts).Hold on apess coz we are going to the moon!![财迷] [财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/a0b07acd6f2159d3c2a5754af6f8fbf5","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":38,"repostSize":0,"link":"https://laohu8.com/post/198725655","isVote":1,"tweetType":1,"viewCount":2458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":130096535,"gmtCreate":1621492504927,"gmtModify":1631885331826,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"Bitcoin hit the lows of $30 000 yeasterday. How low can plays like&nbsp;<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a>go?","listText":"Bitcoin hit the lows of $30 000 yeasterday. How low can plays like&nbsp;<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a>go?","text":"Bitcoin hit the lows of $30 000 yeasterday. How low can plays like $Marathon Digital Holdings Inc(MARA)$go?","images":[{"img":"https://static.tigerbbs.com/60d2cb95f279987c639172cc8a541a30","width":"1080","height":"3514"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":31,"repostSize":0,"link":"https://laohu8.com/post/130096535","isVote":1,"tweetType":1,"viewCount":1779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":105052338,"gmtCreate":1620260964524,"gmtModify":1631886267541,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>A gentle reminder to set up an exit plan!! Aka Stop loss.Also, what is uncle Sam's number?","listText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>A gentle reminder to set up an exit plan!! Aka Stop loss.Also, what is uncle Sam's number?","text":"$Castor Maritime, Inc.(CTRM)$A gentle reminder to set up an exit plan!! Aka Stop loss.Also, what is uncle Sam's number?","images":[{"img":"https://static.tigerbbs.com/9e1edae6152726fdfbfe1448f5bcd222","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":9,"commentSize":29,"repostSize":1,"link":"https://laohu8.com/post/105052338","isVote":1,"tweetType":1,"viewCount":2817,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582127097708653","authorId":"3582127097708653","name":"好运连连823","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":1,"authorIdStr":"3582127097708653","idStr":"3582127097708653"},"content":"我們亦看好這公司，前景好，耐心等待","text":"我們亦看好這公司，前景好，耐心等待","html":"我們亦看好這公司，前景好，耐心等待"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":195469667,"gmtCreate":1621308411859,"gmtModify":1634192562564,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Is the the beginning of the end of the hedgies?&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Is the the beginning of the end of the hedgies?&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;","text":"$AMC Entertainment(AMC)$Is the the beginning of the end of the hedgies? [开心] [开心] [开心] [开心] [开心] [开心]","images":[{"img":"https://static.tigerbbs.com/babe6b3aef512713555e4fd860ea6c94","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":10,"commentSize":27,"repostSize":1,"link":"https://laohu8.com/post/195469667","isVote":1,"tweetType":1,"viewCount":1838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":165691016,"gmtCreate":1624121893635,"gmtModify":1631884617949,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"The view that Bitcoin is a hallmark of speculative excess and froth is still going strong, even after last month's 35% plunge.About 80% of fund managers surveyed by Bank of America Corp. called the market a bubble, up from 75% in May. The poll, which captures the view of 207 investors with $645 billion in assets, said “long Bitcoin” is the second-most crowded trade after commodities.The results point to a skepticism among some professional managers about whether crypto is a viable asset class, given its extreme volatility and regulatory uncertainty. Bubble fears are nothing new for cryptocurrencies, and plenty of investors have voiced doubts over the wisdom of wading into an asset that has no fundamental underpinning.relates to Bitcoin Is Still Being Called a Bubble After May’s 35% CrashEv","listText":"The view that Bitcoin is a hallmark of speculative excess and froth is still going strong, even after last month's 35% plunge.About 80% of fund managers surveyed by Bank of America Corp. called the market a bubble, up from 75% in May. The poll, which captures the view of 207 investors with $645 billion in assets, said “long Bitcoin” is the second-most crowded trade after commodities.The results point to a skepticism among some professional managers about whether crypto is a viable asset class, given its extreme volatility and regulatory uncertainty. Bubble fears are nothing new for cryptocurrencies, and plenty of investors have voiced doubts over the wisdom of wading into an asset that has no fundamental underpinning.relates to Bitcoin Is Still Being Called a Bubble After May’s 35% CrashEv","text":"The view that Bitcoin is a hallmark of speculative excess and froth is still going strong, even after last month's 35% plunge.About 80% of fund managers surveyed by Bank of America Corp. called the market a bubble, up from 75% in May. The poll, which captures the view of 207 investors with $645 billion in assets, said “long Bitcoin” is the second-most crowded trade after commodities.The results point to a skepticism among some professional managers about whether crypto is a viable asset class, given its extreme volatility and regulatory uncertainty. Bubble fears are nothing new for cryptocurrencies, and plenty of investors have voiced doubts over the wisdom of wading into an asset that has no fundamental underpinning.relates to Bitcoin Is Still Being Called a Bubble After May’s 35% CrashEv","images":[{"img":"https://static.tigerbbs.com/4a4cafcf18b072d4613a21ea173c8595","width":"1080","height":"442"},{"img":"https://static.tigerbbs.com/aeb26c1e7f5d5c351fecab6ba908ccdf","width":"1079","height":"713"},{"img":"https://static.tigerbbs.com/0c32fe77f7be9e3dff2f972296d06146","width":"1080","height":"2406"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":16,"commentSize":25,"repostSize":0,"link":"https://laohu8.com/post/165691016","isVote":1,"tweetType":1,"viewCount":1979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},{"id":193268256,"gmtCreate":1620791800875,"gmtModify":1634196257169,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>short borrowing fee steadily rising. NOW AT 81% !!! Why still want to to short this stock??&nbsp;Cost us absolutely&nbsp;nothing to hold.This is the foreplay before the climaxx. Get ready for liftoff boyss. To the mooon!![财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>short borrowing fee steadily rising. NOW AT 81% !!! Why still want to to short this stock??&nbsp;Cost us absolutely&nbsp;nothing to hold.This is the foreplay before the climaxx. Get ready for liftoff boyss. To the mooon!![财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","text":"$AMC Entertainment(AMC)$short borrowing fee steadily rising. NOW AT 81% !!! Why still want to to short this stock?? Cost us absolutely nothing to hold.This is the foreplay before the climaxx. Get ready for liftoff boyss. To the mooon!![财迷] [财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/842fcac3505ad4a9067c061ece0bb123","width":"1080","height":"2160"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":12,"commentSize":26,"repostSize":0,"link":"https://laohu8.com/post/193268256","isVote":1,"tweetType":1,"viewCount":2655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":187066497,"gmtCreate":1623730964219,"gmtModify":1631885374072,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>Friendly reminder to set up stop losses whenever buying punny stocks[流泪]&nbsp;[流泪]&nbsp;[流泪]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>Friendly reminder to set up stop losses whenever buying punny stocks[流泪]&nbsp;[流泪]&nbsp;[流泪]&nbsp;","text":"$Blue Sphere Corp.(BLSP)$Friendly reminder to set up stop losses whenever buying punny stocks[流泪] [流泪] [流泪]","images":[{"img":"https://static.tigerbbs.com/59427b4b891990cc8b4e57952eabb51a","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":29,"repostSize":0,"link":"https://laohu8.com/post/187066497","isVote":1,"tweetType":1,"viewCount":1857,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":102379157,"gmtCreate":1620180281779,"gmtModify":1631887590090,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TRIT\">$Triterras Fintech Pte Ltd.(TRIT)$</a>Patience and disciplineis a virtue that will benefit all traders, keeping emotion and snap judgments in check.[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;&nbsp;","listText":"<a href=\"https://laohu8.com/S/TRIT\">$Triterras Fintech Pte Ltd.(TRIT)$</a>Patience and disciplineis a virtue that will benefit all traders, keeping emotion and snap judgments in check.[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;[得意]&nbsp;&nbsp;","text":"$Triterras Fintech Pte Ltd.(TRIT)$Patience and disciplineis a virtue that will benefit all traders, keeping emotion and snap judgments in check.[得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意] [得意]","images":[{"img":"https://static.tigerbbs.com/fde6ef19a89d54ad97493d44c645eb22","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":30,"repostSize":0,"link":"https://laohu8.com/post/102379157","isVote":1,"tweetType":1,"viewCount":1654,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":131576814,"gmtCreate":1621870293738,"gmtModify":1634185914201,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"Interesting!","listText":"Interesting!","text":"Interesting!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":8,"commentSize":25,"repostSize":0,"link":"https://laohu8.com/post/131576814","repostId":"2137155161","repostType":4,"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":846963846,"gmtCreate":1636040003152,"gmtModify":1636040404124,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>Game over","listText":"<a href=\"https://laohu8.com/S/BLSP\">$Blue Sphere Corp.(BLSP)$</a>Game over","text":"$Blue Sphere Corp.(BLSP)$Game over","images":[{"img":"https://static.tigerbbs.com/7c306791ee819c6714b88d16ce0d7cd3","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":21,"commentSize":17,"repostSize":1,"link":"https://laohu8.com/post/846963846","isVote":1,"tweetType":1,"viewCount":1730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":873707699,"gmtCreate":1636984362449,"gmtModify":1637076725741,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>haizz","listText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>haizz","text":"$Castor Maritime, Inc.(CTRM)$haizz","images":[{"img":"https://static.tigerbbs.com/b8986ce7fc28b2226db12822f70b0d99","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":23,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/873707699","isVote":1,"tweetType":1,"viewCount":2048,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":115196846,"gmtCreate":1622956373485,"gmtModify":1634096586320,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Thankss hedgies!! Averaged up! Hold storng and see you guys at the moon!!!!","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Thankss hedgies!! Averaged up! Hold storng and see you guys at the moon!!!!","text":"$AMC Entertainment(AMC)$Thankss hedgies!! Averaged up! Hold storng and see you guys at the moon!!!!","images":[{"img":"https://static.tigerbbs.com/13164c1c57f742d24e80fd07303b60c3","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":17,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/115196846","isVote":1,"tweetType":1,"viewCount":1750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":185035414,"gmtCreate":1623626646438,"gmtModify":1631884161842,"author":{"id":"3573162818118967","authorId":"3573162818118967","name":"Pepeflabs","avatar":"https://static.tigerbbs.com/bb2ce4a85b6af8ab6f45834a991797c6","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573162818118967","idStr":"3573162818118967"},"themes":[],"htmlText":"The main event on the economic calendar this week will be the Federal Reserve’s rate-setting committee’s June meeting on Tuesday and Wednesday. The committee’s monetary-policy decision and a post-meeting press conference with Chairman Jerome Powell will be the focus of attention on Wednesday afternoon. Talk of inflation and bond-purchase tapering will be on the agenda.Data out this week include the Bureau of Labor Statistics’ producer price index for May and the Census Bureau’s retail-sales data for May, both on Tuesday, followed by the Conference Board’s Leading Economic Index for May on Thursday. There will also be data on the U.S. housing market out on Tuesday and Wednesday.","listText":"The main event on the economic calendar this week will be the Federal Reserve’s rate-setting committee’s June meeting on Tuesday and Wednesday. The committee’s monetary-policy decision and a post-meeting press conference with Chairman Jerome Powell will be the focus of attention on Wednesday afternoon. Talk of inflation and bond-purchase tapering will be on the agenda.Data out this week include the Bureau of Labor Statistics’ producer price index for May and the Census Bureau’s retail-sales data for May, both on Tuesday, followed by the Conference Board’s Leading Economic Index for May on Thursday. There will also be data on the U.S. housing market out on Tuesday and Wednesday.","text":"The main event on the economic calendar this week will be the Federal Reserve’s rate-setting committee’s June meeting on Tuesday and Wednesday. The committee’s monetary-policy decision and a post-meeting press conference with Chairman Jerome Powell will be the focus of attention on Wednesday afternoon. Talk of inflation and bond-purchase tapering will be on the agenda.Data out this week include the Bureau of Labor Statistics’ producer price index for May and the Census Bureau’s retail-sales data for May, both on Tuesday, followed by the Conference Board’s Leading Economic Index for May on Thursday. There will also be data on the U.S. housing market out on Tuesday and Wednesday.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":25,"repostSize":0,"link":"https://laohu8.com/post/185035414","repostId":"1146430910","repostType":4,"isVote":1,"tweetType":1,"viewCount":1019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}